FOLLICULAR LYMPHOMA ( FL)
Clinical trials for FOLLICULAR LYMPHOMA ( FL) explained in plain language.
Never miss a new study
Get alerted when new FOLLICULAR LYMPHOMA ( FL) trials appear
Sign up with your email to follow new studies for FOLLICULAR LYMPHOMA ( FL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New CAR-T therapy trial offers hope for Tough-to-Treat lymphoma
Disease control Not yet recruitingThis study is testing an experimental treatment called TC011, a type of CAR-T cell therapy, in adults whose follicular lymphoma has returned or hasn't responded to at least two prior treatments. The goal is to see if this one-time infusion of a patient's own modified immune cells…
Matched conditions: FOLLICULAR LYMPHOMA ( FL)
Phase: PHASE2 • Sponsor: TICAROS Co., Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Scientists track patients for 15 years after revolutionary cancer cell therapy
Disease control Not yet recruitingThis study aims to monitor the long-term safety and persistence of a CAR-T cell therapy called GF-CART01 for up to 15 years. It will follow 18 patients who previously received this treatment for aggressive B-cell lymphomas that have returned or not responded to other therapies. T…
Matched conditions: FOLLICULAR LYMPHOMA ( FL)
Sponsor: GenomeFrontier Therapeutics TW Co., Ltd. • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Double-Punch T-Cells take aim at stubborn blood cancers
Disease control Not yet recruitingThis early study is testing a new type of cell therapy for patients whose B-cell lymphoma has come back or hasn't responded to other treatments. Doctors will collect a patient's own immune cells, modify them in a lab to attack two specific targets on the cancer cells (CD19 and CD…
Matched conditions: FOLLICULAR LYMPHOMA ( FL)
Phase: EARLY_PHASE1 • Sponsor: First Affiliated Hospital Xi'an Jiaotong University • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Pioneering cancer treatment trial launches in colombia
Disease control Not yet recruitingThis study has two main goals. First, it aims to set up the systems needed to make and deliver a type of personalized cell therapy called CAR-T in Colombia. Second, it will test the safety of this specific CAR-T therapy in a small group of adults with advanced blood cancers that …
Matched conditions: FOLLICULAR LYMPHOMA ( FL)
Phase: NA • Sponsor: GUSTAVO SALGUERO • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC